Neuroendocrine Differentiation in Hormone Refractory Prostate Cancer Following Androgen Deprivation Therapy

Daisaku Hirano, Yasuhiro Okada, Sadatsugu Minei, +2

European Urology

UrologyMedicineNeuroendocrine DisorderNeuroendocrinologyNeuroendocrine Differentiation +5

Increased Expression of Cyclooxygenase‐2 in Local Lesions of Endometriosis Patients

Fumihisa Chishima, Satoshi Hayakawa, Kenji Sugita, +5

American Journal of Reproductive Immunology

Expression of Somatostatin Receptor (SSTR) Subtypes (SSTR-1, 2A, 3, 4 and 5) in Neuroendocrine Tumors Using Real-time RT-PCR Method and Immunohistochemistry

Gou Mizutani, Yoko Nakanishi, Noriko Watanabe, +5

ACTA HISTOCHEMICA ET CYTOCHEMICA

Tumor InnervationMedicineReal-time Rt-pcr MethodImmunologyNeuroendocrine Disorder +10

Analysis of tissue-specific differentially methylated regions (TDMs) in humans

Eiko Kitamura, Jun Igarashi, Aiko Morohashi, +8

Genomics

Epigenetic ChangeDna MethylationEpigenomicsMedicineCell Biology +1

Expression and quantitative analysis of matrix metalloproteinase-2 and-9 in human gliomas

Kyoko Komatsu, Yoko Nakanishi, Norimichi Nemoto, +3

Brain Tumor Pathology

Matrix Metalloproteinase-2 And-9Neuro-oncologyMedicineMetalloproteinQuantitative Analysis +7

Murine fetal resorption and experimental pre-eclampsia are induced by both excessive Th1 and Th2 activation

Satoshi Hayakawa, Tomoyuki Fujikawa, Hideoki Fukuoka, +11

Journal of Reproductive Immunology

Developmental BiologyMurine Fetal ResorptionPhysiologyFetal MedicineGynecology +11

Survivin as a Prognostic Factor for Osteosarcoma Patients

Eiji Osaka, Takashi Suzuki, Shunzo Osaka, +8

ACTA HISTOCHEMICA ET CYTOCHEMICA

Histopathological analysis of angiogenic factors in renal cell carcinoma

Hiroki Yagasaki, Nozomu Kawata, Yukie Takimoto, +1

International Journal of Urology

Activation of WNT/β-Catenin Signaling Enhances Pancreatic Cancer Development and the Malignant Potential Via Up-regulation of Cyr61

Makoto Sano, David R. Driscoll, Wilfredo E De Jesús-Monge, +11

Neoplasia

Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer

Tetsuyo Maeda, Yoko Nakanishi, Yukari Hirotani, +5

Medical Molecular Morphology

Androgen ReceptorBreast OncologyMedicineImmunologyAdjuvant Chemotherapy +7